Biden wants Medicare, Medicaid to cover pricey weight-loss drugs such as Wegovy

Contributing sentiments towards policy:

52% : Under the U.S. Department of Health and Human Services proposed rule, the Biden administration estimates 3.4 million Americans on Medicare would be eligible for the drugs, which can retail for over $1,000 a month.
51% : The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.
45% : Medicare, the federal health program for adults 65 and older, has been prohibited by law from covering weight loss drugs for older Americans who are obese but do not have diabetes or heart disease.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.